Get the Stockscreener App
57.51
1.94%
-1.14
After Hours:
57.51
Vericel Corp Stock (VCEL) Latest News
Jonathan Siegal Sells 1,092 Shares of Vericel Co. (NASDAQ:VCEL) Stock - MarketBeat
Vericel Co. (NASDAQ:VCEL) Director Robert L. Md Zerbe Sells 2,500 Shares - MarketBeat
Vericel (NASDAQ:VCEL) Sets New 52-Week HighHere's Why - MarketBeat
Vericel's principal accounting officer sells $67,693 in stock - MSN
Vericel's principal accounting officer sells $67,693 in stock By Investing.com - Investing.com Australia
Vericel director Robert Zerbe sells $156,250 in stock - MSN
Vericel Co. (NASDAQ:VCEL) Insider Jonathan Siegal Sells 1,092 Shares - Armenian Reporter
Conestoga Capital Advisors LLC Sells 6,300 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
Canaccord Genuity Group Increases Vericel (NASDAQ:VCEL) Price Target to $67.00 - MarketBeat
Vericel Corp [NASDAQ: VCEL] Sees Increase in Stock Value - Knox Daily
Vericel (NASDAQ:VCEL) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
Brokerages Set Vericel Co. (NASDAQ:VCEL) PT at $62.14 - Defense World
Vericel Co. (NASDAQ:VCEL) Receives $62.14 Average Price Target from Analysts - MarketBeat
SG Americas Securities LLC Trims Stock Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
What 7 Analyst Ratings Have To Say About Vericel - Benzinga
Canaccord raises Vericel stock target to $67, maintains buy rating - Investing.com
Vericel Co. (NASDAQ:VCEL) Insider Sells $242,256.92 in Stock - MarketBeat
SG Americas Securities LLC Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel (NASDAQ:VCEL) Sets New 1-Year HighStill a Buy? - MarketBeat
VCEL Stock Touches 52-Week High at $61.5 Amidst Strong Growth - MSN
Park Avenue Securities LLC Takes $280,000 Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Park Avenue Securities LLC Buys Shares of 5,099 Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel (NASDAQ:VCEL) Stock Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
Vericel (NASDAQ:VCEL) Stock Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Burns Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma, Avita Medical, Vericel Corp - The Globe and Mail
Equities Analysts Set Expectations for Vericel Q3 Earnings - MarketBeat
Vericel (NASDAQ:VCEL) Earns “Overweight” Rating from Stephens - Defense World
FY2024 EPS Estimates for Vericel Reduced by HC Wainwright - Defense World
FY2024 Earnings Estimate for Vericel Issued By HC Wainwright - MarketBeat
Vericel expects 2024 net revenue in range of $237 to $237.5 million - MSN
Analyst supports Vericel stock outlook citing MACI Arthro synergies and expansion plans - Investing.com
Vericel (NASDAQ:VCEL) Shares Gap DownShould You Sell? - MarketBeat
Vericel (NASDAQ:VCEL) Receives "Overweight" Rating from Stephens - MarketBeat
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
HC Wainwright Reaffirms "Buy" Rating for Vericel (NASDAQ:VCEL) - MarketBeat
Beyond The Numbers: 5 Analysts Discuss Vericel Stock - Benzinga
Canaccord reaffirms Vericel stock buy rating on preliminary Q4 results - Investing.com
Vericel's preliminary Q4 revenue falls short of analyst expectations; shares fall 11% post market - Investing.com Australia
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets - Yahoo Finance
Vericel Hits Record Q4 Results with 20% Growth, Sets Ambitious 2025 Revenue Targets - StockTitan
Vericel Co. (NASDAQ:VCEL) Receives $61.14 Consensus PT from Analysts - Defense World
JPMorgan Chase & Co. Has $19.08 Million Stake in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 - Yahoo Finance
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $61.14 - MarketBeat
Vericel (NASDAQ:VCEL) Shares Cross Above 200 Day Moving AverageShould You Sell? - MarketBeat
Vericel Corp prices $17 million public offering of common stock - Reuters
5 Best Stem Cell Companies to Invest In (January 2025) - Securities.io
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):